Published in Lancet on May 02, 1998
Parents' perspectives on the MMR immunisation: a focus group study. Br J Gen Pract (2001) 4.60
Concerns about immunisation. BMJ (2000) 2.80
Vaccines and autism: a tale of shifting hypotheses. Clin Infect Dis (2009) 2.10
Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys. Br J Gen Pract (2002) 2.00
Immunisation policy: from compliance to concordance? Br J Gen Pract (2003) 1.86
Lack of association between measles virus vaccine and autism with enteropathy: a case-control study. PLoS One (2008) 1.48
Vaccination and its adverse effects: real or perceived. Society should think about means of linking exposure to potential long term effect. BMJ (1998) 1.34
MMR vaccine: the continuing saga. BMJ (2001) 1.27
Is there a 'regressive phenotype' of Autism Spectrum Disorder associated with the measles-mumps-rubella vaccine? A CPEA Study. J Autism Dev Disord (2006) 1.26
MMR vaccine--worries are not justified. Arch Dis Child (2001) 1.22
Predicting uptake of MMR vaccination: a prospective questionnaire study. Br J Gen Pract (2004) 1.22
A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology. BMC Public Health (2001) 1.20
A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety. Am J Public Health (2004) 1.15
Measles-mumps-rubella vaccine and autistic spectrum disorder: A hypothesis only. Paediatr Child Health (2001) 0.94
Brief report: immune factors in autism: a critical review. J Autism Dev Disord (2002) 0.93
Autistic spectrum disorder: No causal relationship with vaccines. Paediatr Child Health (2007) 0.76
Immunization and children at risk for autism. Paediatr Child Health (2002) 0.76
Autistic spectrum disorder: No causal relationship with vaccines. Can J Infect Dis Med Microbiol (2007) 0.75
Increased Serum Levels of Tumor Necrosis Factor-Alpha, Resistin, and Visfatin in the Children with Autism Spectrum Disorders: A Case-Control Study. Neurol Res Int (2016) 0.75
Is the MMR vaccine safe? West J Med (2001) 0.75
MMR: marginalised, misrepresented and rejected? Autism: a focus group study. Arch Dis Child (2007) 0.75
Measles, mumps and rubella (MMR) vaccination has no effect on cognitive development in children - the results of the Polish prospective cohort study. Vaccine (2013) 0.75
SEQAID: a DNA sequence assembling program based on a mathematical model. Nucleic Acids Res (1984) 6.91
Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics (1977) 4.64
The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med (1994) 4.41
Meningococcal disease: still with us. Rev Infect Dis (1983) 4.36
The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis (1983) 4.05
Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study. Br Med J (Clin Res Ed) (1984) 3.62
Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N Engl J Med (1984) 3.37
Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med (1977) 3.32
A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med (1990) 2.90
Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis (1977) 2.79
High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill (2010) 2.56
Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N Engl J Med (1987) 2.47
Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet (1986) 2.34
Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Lancet (1986) 2.21
Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ (2008) 2.16
A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes (1995) 2.08
Solid phase antibody assay by means of enzyme conjugated to anti-immunoglobulin. J Clin Pathol (1976) 2.03
Antibody response in patients with acute pancreatitis to mycoplasma pneumoniae. Scand J Gastroenterol (1973) 2.03
The polypeptide tunnel system in the ribosome and its gating in erythromycin resistance mutants of L4 and L22. Mol Cell (2001) 1.94
Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. AIDS Res Hum Retroviruses (1996) 1.92
Human rabies of bat origin in Europe. Lancet (1986) 1.85
Measles history and atopic diseases: a population-based cross-sectional study. JAMA (2000) 1.81
Serological diagnosis of Mycoplasma pneumoniae infection by enzyme immunoassay. J Clin Pathol (1980) 1.80
Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J (1995) 1.70
Bile duct injuries during laparoscopic cholecystectomy: a 1994-2001 audit on 13,718 operations in the area of Rome. Surg Endosc (2003) 1.68
The importance of aortic arch or subclavian angiography before coronary reconstruction. Chest (1974) 1.68
The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine (2007) 1.66
Antibody response to capsular polysaccharides of groups A and C neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease. J Infect Dis (1981) 1.65
Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. Pediatrics (1984) 1.65
Low-level air pollution and upper respiratory infections in children. Am J Public Health (1991) 1.63
Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J (2000) 1.56
Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. J Infect Dis (1980) 1.53
Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine. Lancet (1985) 1.52
Narrow- versus broad-spectrum parenteral anatimicrobials against common infections of childhood: a prospective and randomised comparison between penicillin and cefuroxime. Eur J Pediatr (2000) 1.51
Characterization of ATP and DNA binding activities of TrwB, the coupling protein essential in plasmid R388 conjugation. J Biol Chem (1999) 1.50
HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS (1998) 1.50
US of nerve entrapments in osteofibrous tunnels of the upper and lower limbs. Radiographics (2000) 1.49
The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect (2004) 1.49
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol (1998) 1.48
The effect of a recent previous visit to a physician on outcome after childhood bacterial meningitis. JAMA (1994) 1.48
Topology of the components of the DNA packaging machinery in the phage phi29 prohead. J Mol Biol (2000) 1.45
Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics (1994) 1.40
Severity of childhood bacterial meningitis and duration of illness before diagnosis. Lancet (1991) 1.39
A novel neural network technique for analysis and classification of EM single-particle images. J Struct Biol (2001) 1.37
Meningococcal disease in Scandinavia. Br Med J (Clin Res Ed) (1982) 1.35
Prognosis of cryptogenic fibrosing alveolitis. Thorax (1983) 1.34
Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000. Vaccine (2001) 1.34
Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides. Pediatrics (1985) 1.34
Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Am J Epidemiol (1993) 1.32
Mumps and rubella eliminated from Finland. JAMA (2000) 1.32
Changes in erythrocyte sedimentation rate and C-reactive protein after total hip arthroplasty. Clin Orthop Relat Res (1984) 1.31
Immunoblotting and enzyme-linked immunosorbent assay analysis of serological responses in patients infected with herpes simplex virus types 1 and 2. Intervirology (1985) 1.29
Serum C-reactive protein, erythrocyte sedimentation rate and white blood cell count in septic arthritis of children. Pediatr Infect Dis J (1997) 1.28
C-reactive protein in rapid differentiation of acute epiglottitis from spasmodic croup and acute laryngotracheitis: a preliminary report. J Pediatr (1983) 1.25
Seasonal variation in etiology of travelers' diarrhea. Finnish-Moroccan Study Group. J Infect Dis (1992) 1.22
Shift in the age-distribution of meningococcal disease as predictor of an epidemic? Lancet (1982) 1.21
Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J (1989) 1.20
Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children. J Infect Dis (1998) 1.20
Puumala virus infections in Finland: increased occupational risk for farmers. Am J Epidemiol (1999) 1.19
Perinatal cytomegalovirus infection in man. Arch Dis Child (1977) 1.19
Vaccination against meningococcal group A disease in Finland 1974-75. Scand J Infect Dis (1976) 1.19
Group A meningococcal polysaccharide vaccine and course of the group A meningococcal epidemic in Finland. Scand J Infect Dis (1978) 1.19
Childhood bacterial meningitis: initial symptoms and signs related to age, and reasons for consulting a physician. Eur J Pediatr (1987) 1.19
Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites. Eur J Surg Oncol (2006) 1.18
Trips to the South--a health hazard. Morbidity of Finnish travellers. Scand J Infect Dis (1983) 1.17
C reactive protein in the evaluation of febrile illness. Arch Dis Child (1986) 1.16
Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect (2007) 1.15
Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin Infect Dis (1993) 1.15
Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatr Infect Dis J (1995) 1.14
Reappraisal of lung tap: review of an old method for better etiologic diagnosis of childhood pneumonia. Clin Infect Dis (2001) 1.11
Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol (2000) 1.11
Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol Infect (2000) 1.10
Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees. Am J Epidemiol (1998) 1.10
Letter: Negative complement-fixation tests as an immunopathological finding. Lancet (1974) 1.10
Clinical "pneumococcal pneumonia" due to Moraxella osloensis: case report and a review. Scand J Infect Dis (2001) 1.09
Fever, C-reactive protein, and erythrocyte sedimentation rate in monitoring recovery from septic arthritis: a preliminary study. J Pediatr Orthop (1984) 1.08
Oral health indicators poorly predict coronary heart disease deaths. J Dent Res (2003) 1.08
Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies--a prospective study. Cancer Causes Control (1993) 1.07
Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood Diabetes in Finland (DiMe) Study Group. J Infect Dis (1997) 1.07
C-reactive protein compared with white blood cell count and erythrocyte sedimentation rate in the diagnosis of acute appendicitis in children. Acta Chir Scand (1986) 1.06
Modelling the impact of varicella vaccination on varicella and zoster. Epidemiol Infect (2009) 1.06
Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid. J Infect Dis (1987) 1.06
Measles, measles vaccination, and Crohn's disease. Crohn's disease has not increased in Finland. BMJ (1998) 1.05